You are here:

Thrombotic events and COVID-19 vaccines

Published on

Updated:

To ensure that scientific research of immediate concern is shared as rapidly as possible, we fast-track accepted articles from the IJTLD and PHA and publish them as edited preprints prior to publication in a journal.

Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at subscription@theunion.org for details.  Find out more about the IJTLD.

Read the PDF for more information, including the Figures, Tables and References

In this State of the Art, the authors reviewed the literature on thromboembolic adverse events reported after vaccination for COVID-19, and review the benefits and risks of the vaccines approved for use. The findings show that vaccine-induced prothrombotic immune thrombocytopenia are rare adverse events reported mainly in women under 60 years of age. Risk factors for vaccine-induced adverse events should be established so that evidence-based decisions can be made. The preprint is free to read.

Read the PDF for more information, including the Figures, Tables and References